Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Korean Journal of Gynecologic Oncology
>
2005
>
16
Volume:
16
1. A case of Gliomatosis Peritonei after 10 years following Operation of Immature Teratoma of the Ovary.
Page:82—86
2. An analysis of articles published in Korean Journal of Gynecologic Oncology and Colposcopy.
Page:77—81
3. Comparison of the solution of ThinPrep(TM) Pap test with the Cervical Sampler(TM) of Hybrid Capture (HC) II for detecting Human papillomavirus (HPV) DNA.
Page:70—76
4. Human Papillomavirus (HPV) in Lymphatic Fluid of Patients with Cervical Cancer.
Page:61—69
5. The Effect of Hormone Replacement Therapy on Osteoporosis Following Irradiation of Gynecologic Cancer Patients.
Page:53—60
6. Malignant Mixed Mullerian tumors of the ovary: The result of Platinum-based combination chemotherapy following the cytoreductive surgery.
Page:46—52
7. The relation between the preoperative serum level of CA 125 and the stage in endometrial cancer patients.
Page:34—37
8. Diagnosis of Cervical Neoplasia Using Immunohistochemical Staining of p16(INK4A).
Page:27—33
9. Promoter Methylation of p16 Gene in Cervical Cancer.
Page:21—26
10. Genetic Alteration of p16INKA4A Promoter Region in Endometrial Carcinoma.
Page:8—20
11. CpG island methylation and gynecolgic malignancy.
Page:1—7
12. Three cases of squamous cell carcinoma arising in mature cystic teratoma of the ovary.
Page:371—377
13. A case of diffuse large B-cell lymphoma of the uterus and ovary.
Page:366—370
14. Malignant lymphoma originated from uterine cervix and extended to endometrium: A case report.
Page:361—365
15. A clinical study of 15 cases of primary carcinoma of the fallopian tube.
Page:354—360
16. Effects of cell growth inhibition on the combination of cisplatin with green tea extracts.
Page:347—353
17. Differential protein expression of etoposide-treated CaSki cervical carcinoma cells.
Page:333—346
18. The efficacy of HPV DNA chip test in the atypical squamous cell of undetermined significance.
Page:323—332
19. No association between genetic polymorphisms of the Interleukin-4 Receptor alpha gene and cervical cancer in Korean population.
Page:316—322
20. FIGO stage IB clear cell carcinoma and adenocarcinoma of uterine cervix.
Page:307—315
21. Clinicopathologic analysis of patients with uterine papillary serous carcinoma.
Page:300—306
22. Endometrial stromal sarcoma of the uterus: A study of 8 cases.
Page:294—299
23. Relationship between long-term use of tamoxifen and endometrial cancer in patients with breast cancer.
Page:288—293
24. Radiation therapy of cervical cancer: Current status in Korea and recent developments.
Page:279—287
25. A case of retroperitoneal huge smooth muscle tumor misleading to ovarian cancer.
Page:177—181
26. A clinical study on gestational trophoblastic disease.
Page:169—176
27. The efficacy of paclitaxel based combination chemotherapy in recurrent endometrial cancer.
Page:163—168
28. Analysis of prognostic factor and survival in patients with epithelial ovarian cancer treated with combination chemotherapy.
Page:154—162
29. L-myc single nucleotide polymorphism and epithelial ovarian cancer: susceptibility and prognosis in Korean women.
Page:148—153
30. Overexpression of p16(INK4A) as a biomarker for ASCUS in ThinPrep(TM) smear.
Page:141—147
31. Resection margin status and HPV DNA test as predictor of residual lesion after cervical conization in the management of CIN 3.
Page:133—140
32. Correlation between SCC antigen and the prognosis of cervical cancer patients following concurrent chemoradiotherapy.
Page:123—132
33. Immunohistochemical study of 14-3-3-sigma and -zeta in ovarian cancer.
Page:113—122
34. Expression of Matrix Metalloproteinase and Urokinase-type Plasminogen Activator in Epithelial Tumors of the Ovary.
Page:104—112
35. Decreased expression of galectin-3 is associated with the progression of cervical neoplasia.
Page:97—103
36. Role of immunohistochemistry in female genital tract cancer.
Page:87—96
37. Mucinous Borderline tumor associated with Mature Cystic Teratoma of Ovary.
Page:38—45
38. Two cases of synchronous squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Page:273—278
39. Neoadjuvant chemotherapy in cervical carcinoma during pregnancy: Case report.
Page:268—272
40. A case of primary leiomyosarcoma of the mesentery with hepatic metastasis.
Page:264—267
41. Cyclin B1 and D1 expression in invasive cervical cancer.
Page:256—263
42. Transcutaneous DNA vaccination increase the CTL response: Preliminary results for the therapeutic HPV DNA vaccination.
Page:242—255
43. Identification of TACC3 (Transforming Acidic Coiled-Coil 3) as a novel target of paclitaxel-mediated tumor therapy in cervical cancer cells.
Page:229—241
44. The accuracy and cost-effectiveness of triple screening tests in cervical neoplasia.
Page:221—228
45. Contemporary trends of endometrial cancer in Korean women.
Page:215—220
46. Carcinoma in situ of the uterine cervix in pregnancy.
Page:209—214
47. Risk of malignancy index in the preoperative evaluation of ovarian masses.
Page:200—208
48. Comparison of treatment of cervical lesion by use of cold knife conization, electric conizer or large loop.
Page:195—199
49. A clinical study of borderline ovarian tumor: The significance of microinvasion.
Page:189—194
50. Assessment and research of quality of life in gynecologic cancer patients.
Page:182—188